Skip to main content
VCbacked
Log inGet Started

Zentalis Pharmaceuticals

New York, United States

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

$235.5M raised
Jun 2023
Post-IPO Equity
BiopharmaBiotechnologyPharmaceutical

Top Investors

PfizerPerceptive AdvisorsRedmile GroupFarallon Capital ManagementViking Global Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Zentalis Pharmaceuticals

How much funding has Zentalis Pharmaceuticals raised?
Zentalis Pharmaceuticals has raised $235.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2023.
Who are Zentalis Pharmaceuticals's investors?
Zentalis Pharmaceuticals's investors include Pfizer, Perceptive Advisors, Redmile Group, Farallon Capital Management, Viking Global Investors.
Where is Zentalis Pharmaceuticals headquartered?
Zentalis Pharmaceuticals is headquartered in New York, United States.
What does Zentalis Pharmaceuticals do?
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
What stage is Zentalis Pharmaceuticals at?
Zentalis Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Zentalis Pharmaceuticals — Funding & Investors." VCBacked, June 15, 2023, https://www.vcbacked.co/company/zentalis-pharmaceuticals. Accessed July 4, 2026.
APA
VCBacked. (2023). Zentalis Pharmaceuticals — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/zentalis-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Zentalis Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/zentalis-pharmaceuticals |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M